gatifloxacin has been researched along with Pterygium in 2 studies
Gatifloxacin: A fluoroquinolone antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used as an ophthalmic solution for the treatment of BACTERIAL CONJUNCTIVITIS.
gatifloxacin : A monocarboxylic acid that is 4-oxo-1,4-dihydroquinoline-3-carboxylic acid which is substituted on the nitrogen by a cyclopropyl group and at positions 6, 7, and 8 by fluoro, 3-methylpiperazin-1-yl, and methoxy groups, respectively. Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial topoisomerase type-II enzymes.
Pterygium: An abnormal triangular fold of membrane in the interpalpebral fissure, extending from the conjunctiva to the cornea, being immovably united to the cornea at its apex, firmly attached to the sclera throughout its middle portion, and merged with the conjunctiva at its base. (Dorland, 27th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "To compare the rate of corneal epithelial healing and ocular tolerability following pterygium surgery between gatifloxacin and moxifloxacin." | 9.22 | The effect of gatifloxacin 0.3% or moxifloxacin 0.5% on corneal healing, ocular tolerability and toxicity following pterygium surgery. ( Geffen, N; Mimouni, M; Rosen, E; Segev, F, 2016) |
| "To document the development of corneal perforation after using gatifloxacin to treat inflamed pterygium." | 3.74 | Corneal perforation associated with topically applied gatifloxacin. ( Al-Amri, AM, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mimouni, M | 1 |
| Geffen, N | 1 |
| Rosen, E | 1 |
| Segev, F | 1 |
| Al-Amri, AM | 1 |
1 trial available for gatifloxacin and Pterygium
| Article | Year |
|---|---|
The effect of gatifloxacin 0.3% or moxifloxacin 0.5% on corneal healing, ocular tolerability and toxicity following pterygium surgery.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Benzalkonium Compounds; Double-Blind Method; | 2016 |
1 other study available for gatifloxacin and Pterygium
| Article | Year |
|---|---|
Corneal perforation associated with topically applied gatifloxacin.
Topics: Administration, Topical; Adult; Anti-Infective Agents; Cornea; Corneal Diseases; Fluoroquinolones; G | 2008 |